STANOZOLIX 50
Composition : Stanozolol
Stanozolol has been used with some success in treated venous insufficiency. It stimulates blood fibrinolysis and has been evaluated for the treatment of the more advanced skin changes in venous disease such as lipodermatosclerosis. Several randomized trials noted improvement in the area of lipodermatosclerosis, reduced skin thickness, and possibly faster ulcer healing rates with stanozolol. It has also been used to successfully treat hereditary angioedema.
Non-medical uses
Stanozolol is used for physique- and performance-enhancing purposes by competitive athletes, bodybuilders, and powerlifters.
Side effects
See also: Anabolic steroid § Adverse effects
Side effects of stanozolol include virilization (masculinization), hepatotoxicity, and others.
Pharmacokinetics
Stanozolol has high oral bioavailability, due to the presence of its C17α alkyl group and the resistance to gastrointestinal and liver metabolism that it results in. The medication has very low affinityfor human serum sex hormone-binding globulin (SHBG), about 5% of that of testosterone and 1% of that of DHT. Stanozolol is metabolized in the liver, ultimately becoming glucuronide and sulfateconjugates. Its biological half-life is reported to be 9 hours when taken by mouth and 24 hours when given by intramuscular injection in the form of an aqueous suspension.It is said to have a duration of action of one week or more via intramuscular injection.
Contact Us!
